José Ignacio Sánchez-Méndez

7PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpidemiological modellingRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2026
Axillary surgery in the cyclin-dependent kinase 4/6 inhibitors era: no time to move backward.

|Feb 26, 2026
Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer.

Celia Del Monte, Covadonga Martí, Elena Rodríguez

|Jan 25, 2025
A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma.

Víctor Macarrón, Itsaso Losantos-García, Alberto Peláez-García

|Feb 10, 2024
Breast-Conserving Surgery Guided with Magnetic Seeds vs. Wires: A Single-Institution Experience.

Elisa Moreno-Palacios, Covadonga Martí, Laura Frías

|Jun 22, 2023
Surgical Interest of an Accurate Real-World Prediction of Primary Systemic Therapy Response in HER2 Breast Cancers.

Jose Ignacio Sánchez-Méndez, Mónica Horstmann, Nieves Méndez

|Apr 21, 2022
The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study.

Covadonga Martí, Laura Yébenes, José María Oliver

Pageof 2

Frequent Collaborators

3 joint publications

Elisa Moreno-Palacios

2 joint publications

David Hardisson

1 joint publications

Nieves Méndez

1 joint publications

Covadonga Martí